Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DRA anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement HLA-DRA dans FACS et IF. Il présente une réactivité envers Humain.
N° du produit ABIN6937412

Aperçu rapide pour HLA-DRA anticorps (ABIN6937412)

Antigène

Voir toutes HLA-DRA Anticorps
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivité

  • 97
  • 17
  • 10
  • 9
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Humain

Hôte

  • 62
  • 49
  • 4
  • 1
  • 1
Souris

Clonalité

  • 67
  • 50
Monoclonal

Conjugué

  • 59
  • 12
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp HLA-DRA est non-conjugé

Application

  • 55
  • 52
  • 40
  • 34
  • 19
  • 16
  • 13
  • 10
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

IPO-10
  • Specificité

    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. '

    Réactivité croisée (Details)

    Human. Monkey.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Spleen cells of a patient with hairy cell leukemia (Daudi cells)

    Isotype

    IgG3 kappa
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Positive_Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Autre désignation

    HLA-DRA

    Sujet

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA,HLA-DRA (MHC II)
    Cellular localisation: Cell surface

    Poids moléculaire

    ~36kDa

    ID gène

    3122, 520048

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!